Any current/future new fundraising through debt or equity?

There is no explicit mention of any ongoing or planned new fundraising through debt or equity in the call. The company currently holds approximately Rs. 99 crores in cash and bank balance, including investments. Sameer Merchant indicated that since day one, the company remains open to acquisition or merger opportunities if they add value, but will announce details only when finalized. The company remains debt-free with finance costs reducing from Rs. 1.3 crores last year to Rs. 0.3 crores this quarter. Future CAPEX will be funded using the existing IPO proceeds. No specific plans for raising a

Any current/future capex/capital investment/strategic investment?

Laxmi Dental plans to deploy CAPEX based on operational capabilities and revenue growth. In FY '26, they executed CAPEX of around Rs. 18.4 crores. The company has IPO proceeds of approximately Rs. 99 crores available for further capital expenditure. CAPEX will be balanced and phased according to revenue growth and operational needs. No specific acquisition or merger details shared yet, but management is open to opportunities that add value. Focus remains on organic growth with eyes open for strategic deals if they benefit the company. Investments continue in digital dentistry and automation to

Future growth expectations in sales/revenue/volumes?

The company aims to grow at a similar trajectory as the past years; last two years saw 24% and 16% growth respectively, despite challenges (Page 11). Management is confident in achieving broad-based growth across all segments in the medium to long term (Page 4, Page 16). Dental lab business (domestic and international) is expected to see meaningful scale-up over next 2-3 years (Page 9). Export revenue (currently 33-34%) has tremendous potential alongside domestic; focus will be opportunity-driven (Page 11). Scanner deployment strategy supports higher growth for scanner-equipped dentists, enhan

Future growth expectations in earnings/operating earnings/profits/EPS?

Company aims to maintain or improve EBITDA margins around 18%-20% and gross margins of 75%-80% by FY '27 or FY '28. PAT margins targeted at 13%-15%, with management confident about sustaining or improving current performance. Despite micro-dynamic challenges beyond control, prior years' growth rates (~16%) during tough periods indicate resilience and potential to sustain similar growth in coming two to three years. Export business, currently 33%-34% of revenue, and domestic business both have significant growth potential; company to focus on opportunities as they arise. Scanner business contri

Current/ Expected Orderbook/ Pending Orders?

The company did not provide specific numbers regarding the current or expected order book or pending orders in the call. Sameer Merchant mentioned being in an "active phase of registration" for international markets but did not specify timelines or order volumes. Business momentum is positive, with strong domestic and international growth, and digital penetration at 80%, targeting 90%. Scanner deployment is ongoing, contributing to higher revenue growth from digital dentists. Management remains confident about growth prospects but refrains from giving fixed timelines or detailed order book dat

IN US

Sale is live|00:00:00left today

Laxmi Dental LtdQ1 FY26Healthcare Equipment & Supplies

Laxmi Dental Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹225P/E: 44.1Market Cap: ₹1.2K CrSector: Healthcare Equipment & Supplies

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company aims to grow at a similar trajectory as the past years; last two years saw 24% and 16% growth respectively, despite challenges (Page 11).
→Management is confident in achieving broad-based growth across all segments in the medium to long term (Page 4, Page 16).
→Dental lab business (domestic and international) is expected to see meaningful scale-up over next 2-3 years (Page 9).
→Export revenue (currently 33-34%) has tremendous potential alongside domestic; focus will be opportunity-driven (Page 11).
→Scanner deployment strategy supports higher growth for scanner-equipped dentists, enhancing aligner and lab business volumes (Page 8).
→Aligner business is growing, with Bizdent recovering and Vedia expected to grow further internationally (Page 8-9).
→The domestic market still has significant untapped potential, with about 22,000 dentists engaged out of 300,000+ in India (Page 17).
→Company adopting balanced approach focused on sustainable growth without compromising margins (Page 8).

Margin guidance

Category 3

→Company aims to maintain or improve EBITDA margins around 18%-20% and gross margins of 75%-80% by FY '27 or FY '28.
→PAT margins targeted at 13%-15%, with management confident about sustaining or improving current performance.
→Despite micro-dynamic challenges beyond control, prior years' growth rates (~16%) during tough periods indicate resilience and potential to sustain similar growth in coming two to three years.
→Export business, currently 33%-34% of revenue, and domestic business both have significant growth potential; company to focus on opportunities as they arise.
→Scanner business contributes to operational leverage and digital dentistry expansion, supporting margin improvement.
→Capital expenditure to be deployed prudently, supporting operational capabilities aligned with revenue growth.
→The company is cautiously optimistic but refrains from giving precise CAGR guidance, focusing on balanced growth with maintained margins.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no explicit mention of any ongoing or planned new fundraising through debt or equity in the call.
→The company currently holds approximately Rs. 99 crores in cash and bank balance, including investments.
→Sameer Merchant indicated that since day one, the company remains open to acquisition or merger opportunities if they add value, but will announce details only when finalized.
→The company remains debt-free with finance costs reducing from Rs. 1.3 crores last year to Rs. 0.3 crores this quarter.
→Future CAPEX will be funded using the existing IPO proceeds.
→No specific plans for raising additional funds through debt or equity were disclosed during the discussion.

Order book

→The company did not provide specific numbers regarding the current or expected order book or pending orders in the call.
→Sameer Merchant mentioned being in an "active phase of registration" for international markets but did not specify timelines or order volumes.
→Business momentum is positive, with strong domestic and international growth, and digital penetration at 80%, targeting 90%.
→Scanner deployment is ongoing, contributing to higher revenue growth from digital dentists.
→Management remains confident about growth prospects but refrains from giving fixed timelines or detailed order book data due to regulatory uncertainties and market variables.
→They prefer announcing achievements like registration completions rather than speculative timelines on order inflows.
→Overall, the company shows optimism about the growth opportunity but avoids quantifying exact pending orders or order book size at this stage.

Capex plans

Yes

→Laxmi Dental plans to deploy CAPEX based on operational capabilities and revenue growth.
→In FY '26, they executed CAPEX of around Rs. 18.4 crores.
→The company has IPO proceeds of approximately Rs. 99 crores available for further capital expenditure.
→CAPEX will be balanced and phased according to revenue growth and operational needs.
→No specific acquisition or merger details shared yet, but management is open to opportunities that add value.
→Focus remains on organic growth with eyes open for strategic deals if they benefit the company.
→Investments continue in digital dentistry and automation to improve operational efficiencies.
→Scanner deployment is a strategic priority to drive growth in laboratory and aligner business segments.

How does Laxmi Dental Ltd rank vs peers in Healthcare Equipment & Supplies?

Pro feature

1Laxmi Dental Ltd

Rev 3Mar 3

See full Healthcare Equipment & Supplies sector rankings

Want more stocks like Laxmi Dental Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio